Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ancard.2020.10.004 http://scihub22266oqcxt.onion/10.1016/j.ancard.2020.10.004 33092785!7543685!33092785     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33092785&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Ann+Cardiol+Angeiol+(Paris) 2020 ; 69 (6): 360-364 Nephropedia Template TP {{tp|p=33092785|t=2020. COVID-19 et assistance circulatoire |pdf=|usr=}}{{33092785}} gab.com Text COVID-19 et assistance circulatoire JO: Ann Cardiol Angeiol (Paris) http://www.kidney.de/pget.php?&tw=1&pmid=33092785 #FOAvip Extracorporeal membrane oxygenation (ECMO) is mainly used as a rescue therapy in COVID-19 patients with severe acute respiratory distress syndrome (ARDS). More rarely, COVID-19 can be complicated by hemodynamic failure due to fulminant myocarditis or massive pulmonary embolism necessitating the implantation of venous-arterial ECMO. The management of ECMO during the COVID-19 pandemic is challenging due to some specificities related to the disease characteristics, such as the management of anticoagulation in patients with a hypercoagulable state and an increased risk of venous thromboembolism. In large retrospective cohorts, survival of ECMO-rescued COVID-19 patients with ADRS was reported to be similar to that reported in previous studies on ECMO support for severe ARDS. Full consideration of ECMO candidacy is crucial for appropriate allocation of resources. Twit Text FOAVip COVID-19 et assistance circulatoire ????Ann Cardiol Angeiol (Paris) http://www.kidney.de/pget.php?&tw=1&pmid=33092785 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33092785 #FOAvip English Wikipedia <ref>{{Cite pmid|33092785}}</ref> COVID-19 et assistance circulatoire #MMPMID33092785 Hekimian G; Frere C; Collet JP Ann Cardiol Angeiol (Paris) 2020[Dec]; 69 (6): 360-364 PMID33092785show ga Extracorporeal membrane oxygenation (ECMO) is mainly used as a rescue therapy in COVID-19 patients with severe acute respiratory distress syndrome (ARDS). More rarely, COVID-19 can be complicated by hemodynamic failure due to fulminant myocarditis or massive pulmonary embolism necessitating the implantation of venous-arterial ECMO. The management of ECMO during the COVID-19 pandemic is challenging due to some specificities related to the disease characteristics, such as the management of anticoagulation in patients with a hypercoagulable state and an increased risk of venous thromboembolism. In large retrospective cohorts, survival of ECMO-rescued COVID-19 patients with ADRS was reported to be similar to that reported in previous studies on ECMO support for severe ARDS. Full consideration of ECMO candidacy is crucial for appropriate allocation of resources. |*Extracorporeal Membrane Oxygenation[MESH] |COVID-19/*complications[MESH] |Humans[MESH]COVID-19 et assistance circulatoire (epmc).pdf DeepDyve Pubget Overpricing